Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy
- Resource Type
- Source
- Blood Advances. 6:5222-5226
- Subject
Neoplasms Antigens, CD19 Receptors, Antigen, T-Cell Humans Hematology Immunotherapy, Adoptive - Language
- ISSN
- 2473-9537
2473-9529